Matchpoint Therapeutics Company
Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.
Industry:
Early Drug Development
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2021-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
6
Total Funding:
100000000
Last Funding Date:
2022-10-14
Last Funding Type:
Series A
Register and Claim Ownership